Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam in Status Epilepticus
NCT00362141Phase 2Unknown
- Sponsor
- Haaglanden Medical Centre
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of levetiracetam in status epilepticus (SE), sponsored by Haaglanden Medical Centre. Primary endpoint: Safety and Tolerability of IV Levetiracetam. Status: unknown.
02
Drugs
levetiracetam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT00362141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362141.